Quantum Pacific Capital

Quantum Pacific Capital Ltd. is a private equity firm that specializes in acquiring, owning, operating, and managing businesses in various sectors, including natural resources, power and infrastructure, media, and telecommunications. The firm focuses on both greenfield and brownfield investments in power and infrastructure, seeking opportunities with shorter payback periods and minimal reliance on government support. In the telecommunications sector, Quantum Pacific targets investments in mobile and wireless technologies across the ASEAN region. Primarily active in Asia, Australia, and North America, the firm has its headquarters in Central, Hong Kong, and maintains partner offices in Singapore, Vancouver, and Los Angeles.

Idan Ofer

Principal

2 past transactions

EkWateur

Series B in 2022
EkWateur is a French energy retailer established in 2015 with the aim of becoming a significant player in the country's energy market. The company offers its customers 100% renewable electricity at competitive prices, along with natural gas and wood fuel options for both residential and business clients. EkWateur stands out by providing an innovative, user-friendly platform that enables seamless switching to greener energy sources in just a few clicks. Its mission is to accelerate the transition towards cleaner energy by increasing demand for renewables, thereby encouraging large-scale producers to replace fossil fuels.

Indel Therapeutics

Series B in 2011
Indel Therapeutics Inc. is a Vancouver‐based biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company has a growing pipeline of novel antibiotic drug discovery programs focused on curing difficult‐to‐treat and hospital‐acquired infections. These programs are based on Indel's paradigm‐changing antimicrobial drug discovery platform, a patented technology that that has opened a rich, new area of antimicrobial drug targets for the treatment of infectious diseases and has the potential to provide an advantage against drug resistance.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.